Crossmark

The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making

Crossref DOI link: https://doi.org/10.1186/s12916-023-02929-0

Published Online: 2023-07-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hutubessy, Raymond

Lauer, Jeremy A.

Giersing, Birgitte

Sim, So Yoon

Jit, Mark

Kaslow, David

Botwright, Siobhan
License Information

Text and Data Mining valid from 2023-07-04

Version of Record valid from 2023-07-04
More Information

Article History

Received: 18 October 2022

Accepted: 8 June 2023

First Online: 4 July 2023

Declarations

:

: This study did not receive nor require ethics approval, as it does not involve human and animal participants.

: The analysis reported here did not include study participants or members of the public.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below